Skip to main content

Table 4 Factors associated with Disease Free Survival—overall population

From: Role of patient and tumor characteristics in sentinel lymph node metastasis in patients with luminal early breast cancer: an observational study

 

Univariate HR (95 % CI)

p value

Multivariate HR (95 % CI)

p value

Age (increase of 10 years)

0.74 (0.56–0.97)

0.027

0.83 (0.63–1.10)

0.194

Tumor size (increase of 10 mm)

1.33 (0.98–1.81)

0.064

1.01 (0.68–1.49)

0.961

Histological grade

    

 Grade 1 (reference)

1

 

1

 

 Grade 2

2.03 (0.59–7.01)

0.264

1.84 (0.52–6.56)

0.347

 Grade 3

5.73 (1.73–19.04)

0.004

2.39 (0.62–9.17)

0.205

Subtype

    

 Luminal A

1

   

 Luminal B

2.11 (0.95–4.73)

0.067

1.62 (0.69–3.79)

0.267

 HER2

5.68 (2.18–14.74)

0.0004

3.88 (1.34–11.25)

0.013

 Triple negative

9.36 (4.04–21.67)

<.0001

5.94 (2.09–16.85)

0.0008

SLN positivity

    

 No metastasis

1

   

 Positive metastasis

1.68 (0.89–3.16)

0.108

  

SLN pattern

    

 No metastasis

1

   

 Micrometastasis

1.72 (0.71–4.18)

0.230

  

 Macrometastasis

1.65 (0.77–3.51)

0.193

  

Presence of LVI (yes vs. no)

1.84 (0.98–3.44)

0.057

1.19 (0.60–2.33)

0.622

  1. SLN Sentinel Lymph Node, LVI LymphoVascular Invasion